Literature DB >> 14966384

Glucocorticoid-induced apoptosis in CNS microvascular pericytes.

Andre Katychev1, Xueqain Wang, Alexandra Duffy, Paula Dore-Duffy.   

Abstract

Pericyte loss or migration from its vascular location may be an important step in microvascular remodeling. Decreased pericyte to endothelial ratios are characteristics of newly formed vessels as well as microvessels undergoing regression, and may be due to selective degeneration via necrotic cell death or via programmed cell death. In this study, we have examined glucocorticoid-induced apoptosis in primary rat CNS pericytes. Characterization of apoptosis was determined using five independent criteria: (1) the translocation of receptors for annexin V from the inner to the outer surface of the plasma membrane, (2) the translocation of cytochrome C from the mitochondria to the cytosol, (3) the induction of DNA fragmentation, (4) the induction of classic changes in cell morphology, and (5) the appearance of TUNEL-positive cells. Incubation of CNS pericytes with dexamethasone induced the appearance of apoptotic cells in a time- and dose-dependent manner. Pericytes express immunologically detectable glucocorticoid receptors, and addition of the glucocorticoid receptor antagonist mifepristone inhibited dexamethasone-induced pericyte apoptosis. That pericytes undergo apoptosis in response to dexamethasone suggests that the regulatory function of this steroid may be important in vascular development and that pericyte apoptotic cell death may accompany vascular regression. Deregulation of pericyte involvement in vascular homeostasis and hemostasis may result in clinical disease. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14966384     DOI: 10.1159/000075669

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  6 in total

1.  Changes in the vascular area fraction of the hippocampus and amygdala are induced by prenatal dexamethasone and/or adult stress.

Authors:  Gretchen N Neigh; Michael J Owens; W Robert Taylor; Charles B Nemeroff
Journal:  J Cereb Blood Flow Metab       Date:  2010-04-07       Impact factor: 6.200

2.  Regulation of bim in glucocorticoid-mediated osteoblast apoptosis.

Authors:  B Espina; M Liang; R G G Russell; P A Hulley
Journal:  J Cell Physiol       Date:  2008-05       Impact factor: 6.384

3.  Topiramate treatment protects blood-brain barrier pericytes from hyperglycemia-induced oxidative damage in diabetic mice.

Authors:  Tulin O Price; Vijay Eranki; William A Banks; Nuran Ercal; Gul N Shah
Journal:  Endocrinology       Date:  2011-11-22       Impact factor: 4.736

Review 4.  Neurovascular glucocorticoid receptors and glucocorticoids: implications in health, neurological disorders and drug therapy.

Authors:  Sherice Williams; Chaitali Ghosh
Journal:  Drug Discov Today       Date:  2019-09-18       Impact factor: 7.851

5.  Neuroprotection of Intermedin Against Cerebral Ischemia/Reperfusion Injury Through Cerebral Microcirculation Improvement and Apoptosis Inhibition.

Authors:  Xin Guo; Jie Yuan; Meixi Li; Meng Wang; Peiyuan Lv
Journal:  J Mol Neurosci       Date:  2020-09-10       Impact factor: 3.444

6.  Tissue-specific actions of glucocorticoids on apoptosis: a double-edged sword.

Authors:  Amanda L Gruver-Yates; John A Cidlowski
Journal:  Cells       Date:  2013-03-26       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.